Search - tctmd.com

Displaying 721 - 740 of 1535

Sort: Relevancy | Date

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

February 20, 2019

Atherosclerosis Features Differ Among Male Athletes From Different Sports

News Daily News

Atherosclerosis Features Differ Among Male Athletes From Different Sports

February 18, 2019

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

News Daily News

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

February 12, 2019

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

January 22, 2019

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention--With Some Caveats

News Daily News

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

January 21, 2019

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

News Daily News

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

January 18, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

January 11, 2019

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

News Daily News

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

January 09, 2019

TCTMD’s Top 10 Most Popular Stories for December 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

January 01, 2019

Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure

News Daily News

Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure

Yael L. Maxwell

December 17, 2018

Hospitals With Higher SAVR Mortality Likely to Have Higher TAVR Mortality, Too

News Daily News

Hospitals With Higher SAVR Mortality Likely to Have Higher TAVR Mortality, Too

December 12, 2018

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

December 11, 2018

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

NOACs Significantly Curb Risk of VTE in Cancer Patients

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

December 06, 2018

Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe

News Features

Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe

November 30, 2018

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

News Daily News

Global Investigative Journalism Initiative Takes Aim at Medical Device Industry

November 26, 2018

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

November 21, 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.